Viagra Label May Note Rare Vision Problems.

May 27, 2007 — Viagra’s marking may result to reflect rare sense experience problems reported by a few men who have used the erectile dysfunction drug.
Viagra’s shaper, Pfizer, issued a melodic theme saying it is “in discussions with the [FDA] to update the sildenafil radioisotope to reflect these rare ocular occurrences.
“Viagra has a strong condition visibility and corpse an effective medicine that benefits millions of patients,” says the substance.
Pfizer says a variety show of 103 clinical trials of viagra — including 13,000 patients — found no reports of the eye difficulty, which is called nonarteritic anterior ischemic optic neuropathy (NAION).
WebMD reported on the substance in April, when ophthalmologist Leslie Howard Pomeranz, MD, PhD, published a paper describing 14 cases of NAION in men taking sildenafil .
sildenafil has been used by 23 gazillion men worldwide, says Pfizer’s idea.
The pharmaceutical circle is a WebMD helper.
A call to the FDA for input was not returned before business.
This is a part of article Viagra Label May Note Rare Vision Problems. Taken from "Viagra Soft" Information Blog